

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | desmosome organization (GO:0002934) | 7.98980082 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.74934261 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 5.74934261 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.42241593 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 5.42241593 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 5.21052480 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.07308890 |
| 8 | * multicellular organismal water homeostasis (GO:0050891) | 4.97049751 |
| 9 | bile acid biosynthetic process (GO:0006699) | 4.81711324 |
| 10 | tryptophan catabolic process (GO:0006569) | 4.81707228 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 4.81707228 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 4.81707228 |
| 13 | negative regulation of fibrinolysis (GO:0051918) | 4.80522630 |
| 14 | regulation of fibrinolysis (GO:0051917) | 4.79644351 |
| 15 | kynurenine metabolic process (GO:0070189) | 4.77779067 |
| 16 | regulation of protein activation cascade (GO:2000257) | 4.77270613 |
| 17 | high-density lipoprotein particle remodeling (GO:0034375) | 4.75135433 |
| 18 | protein carboxylation (GO:0018214) | 4.68782902 |
| 19 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.68782902 |
| 20 | phospholipid efflux (GO:0033700) | 4.66311143 |
| 21 | glyoxylate metabolic process (GO:0046487) | 4.63449203 |
| 22 | tryptophan metabolic process (GO:0006568) | 4.58410335 |
| 23 | regulation of complement activation (GO:0030449) | 4.49689405 |
| 24 | complement activation, alternative pathway (GO:0006957) | 4.47426198 |
| 25 | regulation of triglyceride catabolic process (GO:0010896) | 4.42689068 |
| 26 | fibrinolysis (GO:0042730) | 4.42503228 |
| 27 | hemidesmosome assembly (GO:0031581) | 4.40889860 |
| 28 | urea cycle (GO:0000050) | 4.36916738 |
| 29 | urea metabolic process (GO:0019627) | 4.36916738 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 4.31980063 |
| 31 | cysteine metabolic process (GO:0006534) | 4.29864598 |
| 32 | reverse cholesterol transport (GO:0043691) | 4.21282970 |
| 33 | intestinal cholesterol absorption (GO:0030299) | 4.20149756 |
| 34 | alpha-linolenic acid metabolic process (GO:0036109) | 4.18349278 |
| 35 | * water homeostasis (GO:0030104) | 4.16537335 |
| 36 | exogenous drug catabolic process (GO:0042738) | 4.09487887 |
| 37 | amino-acid betaine metabolic process (GO:0006577) | 4.03275710 |
| 38 | regulation of cholesterol esterification (GO:0010872) | 3.99030464 |
| 39 | plasma lipoprotein particle remodeling (GO:0034369) | 3.97452806 |
| 40 | protein-lipid complex remodeling (GO:0034368) | 3.97452806 |
| 41 | macromolecular complex remodeling (GO:0034367) | 3.97452806 |
| 42 | bile acid metabolic process (GO:0008206) | 3.97239966 |
| 43 | nitrogen cycle metabolic process (GO:0071941) | 3.96105705 |
| 44 | uronic acid metabolic process (GO:0006063) | 3.93311070 |
| 45 | glucuronate metabolic process (GO:0019585) | 3.93311070 |
| 46 | keratinization (GO:0031424) | 3.90820887 |
| 47 | drug catabolic process (GO:0042737) | 3.90579531 |
| 48 | negative regulation of lipase activity (GO:0060192) | 3.90122632 |
| 49 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.87898054 |
| 50 | homocysteine metabolic process (GO:0050667) | 3.87776059 |
| 51 | cell adhesion mediated by integrin (GO:0033627) | 3.84711472 |
| 52 | negative regulation of protein activation cascade (GO:2000258) | 3.83666668 |
| 53 | primary alcohol catabolic process (GO:0034310) | 3.82019129 |
| 54 | serine family amino acid catabolic process (GO:0009071) | 3.81218537 |
| 55 | tyrosine metabolic process (GO:0006570) | 3.81079311 |
| 56 | acylglycerol homeostasis (GO:0055090) | 3.80772278 |
| 57 | triglyceride homeostasis (GO:0070328) | 3.80772278 |
| 58 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.80047384 |
| 59 | plasma lipoprotein particle clearance (GO:0034381) | 3.78130094 |
| 60 | skin morphogenesis (GO:0043589) | 3.78114090 |
| 61 | aromatic amino acid family metabolic process (GO:0009072) | 3.74989373 |
| 62 | molting cycle (GO:0042303) | 3.72151152 |
| 63 | hair cycle (GO:0042633) | 3.72151152 |
| 64 | gap junction assembly (GO:0016264) | 3.71785262 |
| 65 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.68934254 |
| 66 | imidazole-containing compound metabolic process (GO:0052803) | 3.68710622 |
| 67 | negative regulation of sterol transport (GO:0032372) | 3.68336507 |
| 68 | negative regulation of cholesterol transport (GO:0032375) | 3.68336507 |
| 69 | fatty acid elongation (GO:0030497) | 3.67373973 |
| 70 | regulation of plasminogen activation (GO:0010755) | 3.62363653 |
| 71 | epoxygenase P450 pathway (GO:0019373) | 3.58754605 |
| 72 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.57835640 |
| 73 | cholesterol efflux (GO:0033344) | 3.57634469 |
| 74 | negative regulation of coagulation (GO:0050819) | 3.56990300 |
| 75 | negative regulation of wound healing (GO:0061045) | 3.56044100 |
| 76 | ethanol metabolic process (GO:0006067) | 3.55261415 |
| 77 | positive regulation of lipid catabolic process (GO:0050996) | 3.52432738 |
| 78 | regulation of phospholipase A2 activity (GO:0032429) | 3.52268113 |
| 79 | cell-substrate junction assembly (GO:0007044) | 3.47020070 |
| 80 | bile acid and bile salt transport (GO:0015721) | 3.46641209 |
| 81 | polyketide metabolic process (GO:0030638) | 3.46021205 |
| 82 | doxorubicin metabolic process (GO:0044598) | 3.46021205 |
| 83 | daunorubicin metabolic process (GO:0044597) | 3.46021205 |
| 84 | response to phenylpropanoid (GO:0080184) | 3.45885540 |
| 85 | linoleic acid metabolic process (GO:0043651) | 3.43235753 |
| 86 | cellular modified amino acid catabolic process (GO:0042219) | 3.41601122 |
| 87 | plasma lipoprotein particle assembly (GO:0034377) | 3.41522354 |
| 88 | lysine catabolic process (GO:0006554) | 3.40014341 |
| 89 | lysine metabolic process (GO:0006553) | 3.40014341 |
| 90 | regulation of cholesterol homeostasis (GO:2000188) | 3.39544339 |
| 91 | blood coagulation, intrinsic pathway (GO:0007597) | 3.38916384 |
| 92 | alpha-amino acid catabolic process (GO:1901606) | 3.36727412 |
| 93 | indolalkylamine metabolic process (GO:0006586) | 3.36245729 |
| 94 | glutamate metabolic process (GO:0006536) | 3.32395715 |
| 95 | benzene-containing compound metabolic process (GO:0042537) | 3.30895393 |
| 96 | keratinocyte proliferation (GO:0043616) | 3.30785037 |
| 97 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.30632047 |
| 98 | protein activation cascade (GO:0072376) | 3.29731141 |
| 99 | * regulation of water loss via skin (GO:0033561) | 3.28094666 |
| 100 | * establishment of skin barrier (GO:0061436) | 3.26994623 |
| 101 | very long-chain fatty acid metabolic process (GO:0000038) | 3.26524322 |
| 102 | epidermis development (GO:0008544) | 3.25484722 |
| 103 | complement activation (GO:0006956) | 3.25395677 |
| 104 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.24036146 |
| 105 | ethanol oxidation (GO:0006069) | 3.23056442 |
| 106 | cellular ketone body metabolic process (GO:0046950) | 3.22881952 |
| 107 | cholesterol homeostasis (GO:0042632) | 3.22698954 |
| 108 | cellular biogenic amine catabolic process (GO:0042402) | 3.22325831 |
| 109 | amine catabolic process (GO:0009310) | 3.22325831 |
| 110 | positive regulation of blood coagulation (GO:0030194) | 3.22055090 |
| 111 | positive regulation of hemostasis (GO:1900048) | 3.22055090 |
| 112 | cellular glucuronidation (GO:0052695) | 3.20709495 |
| 113 | regulation of apoptotic cell clearance (GO:2000425) | 3.18210899 |
| 114 | sterol homeostasis (GO:0055092) | 3.16658663 |
| 115 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.16020223 |
| 116 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.16020223 |
| 117 | negative regulation of complement activation (GO:0045916) | 3.15640457 |
| 118 | negative regulation of hemostasis (GO:1900047) | 3.15069956 |
| 119 | negative regulation of blood coagulation (GO:0030195) | 3.15069956 |
| 120 | omega-hydroxylase P450 pathway (GO:0097267) | 3.14952566 |
| 121 | keratinocyte differentiation (GO:0030216) | 3.12309471 |
| 122 | epithelial cell-cell adhesion (GO:0090136) | 3.11772908 |
| 123 | carnitine metabolic process (GO:0009437) | 3.11510904 |
| 124 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.11212095 |
| 125 | cellular amino acid catabolic process (GO:0009063) | 3.10718766 |
| 126 | complement activation, classical pathway (GO:0006958) | 3.09932173 |
| 127 | polarized epithelial cell differentiation (GO:0030859) | 3.09850751 |
| 128 | low-density lipoprotein particle remodeling (GO:0034374) | 3.09546302 |
| 129 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.08495729 |
| 130 | establishment of planar polarity (GO:0001736) | 3.08134107 |
| 131 | establishment of tissue polarity (GO:0007164) | 3.08134107 |
| 132 | surfactant homeostasis (GO:0043129) | 3.06452202 |
| 133 | positive regulation of coagulation (GO:0050820) | 3.03694987 |
| 134 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.03046963 |
| 135 | epidermal cell differentiation (GO:0009913) | 2.99727816 |
| 136 | phenylpropanoid metabolic process (GO:0009698) | 2.98333794 |
| 137 | lateral sprouting from an epithelium (GO:0060601) | 2.98250181 |
| 138 | atrioventricular valve morphogenesis (GO:0003181) | 2.95741916 |
| 139 | acute-phase response (GO:0006953) | 2.90443215 |
| 140 | positive regulation of extracellular matrix organization (GO:1903055) | 2.90136412 |
| 141 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.88540392 |
| 142 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.88479469 |
| 143 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.81042095 |
| 144 | retinal metabolic process (GO:0042574) | 2.80195014 |
| 145 | COPI coating of Golgi vesicle (GO:0048205) | 2.75704575 |
| 146 | Golgi transport vesicle coating (GO:0048200) | 2.75704575 |
| 147 | intermediate filament organization (GO:0045109) | 2.73205847 |
| 148 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.69557864 |
| 149 | regulation of humoral immune response (GO:0002920) | 2.69346504 |
| 150 | peptide cross-linking (GO:0018149) | 2.68342504 |
| 151 | drug metabolic process (GO:0017144) | 2.68172417 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 9.58626435 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.60377312 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.27068914 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.66693318 |
| 5 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.50482561 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.33452383 |
| 7 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.16933769 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.55017352 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.22724359 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.71305183 |
| 11 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.69672068 |
| 12 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.06356174 |
| 13 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.97648297 |
| 14 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.90069831 |
| 15 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.79957796 |
| 16 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.78643911 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.68284111 |
| 18 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.66908438 |
| 19 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.65989945 |
| 20 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.59553406 |
| 21 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.59379211 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.55891150 |
| 23 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.48226641 |
| 24 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.48024081 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.45717754 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.45270095 |
| 27 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.38924274 |
| 28 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.38411271 |
| 29 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.31694999 |
| 30 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.31694999 |
| 31 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.26446275 |
| 32 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.23185464 |
| 33 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.21672331 |
| 34 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.20198619 |
| 35 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.18055585 |
| 36 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.16620198 |
| 37 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.15414640 |
| 38 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.14357195 |
| 39 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.13494982 |
| 40 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.13088705 |
| 41 | CJUN_26792858_Chip-Seq_BT549_Human | 1.10868482 |
| 42 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.10487287 |
| 43 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.09435465 |
| 44 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.08643167 |
| 45 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.07887138 |
| 46 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.07018581 |
| 47 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.06645203 |
| 48 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.05473751 |
| 49 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.02015188 |
| 50 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01885445 |
| 51 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.99386237 |
| 52 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.98528109 |
| 53 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.96829460 |
| 54 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.96829460 |
| 55 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95047553 |
| 56 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92049336 |
| 57 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91974754 |
| 58 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90895891 |
| 59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.90857593 |
| 60 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89948073 |
| 61 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.89544003 |
| 62 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.88875852 |
| 63 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.88739367 |
| 64 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88267499 |
| 65 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.88049055 |
| 66 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87654141 |
| 67 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.87324483 |
| 68 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.87324483 |
| 69 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.85336996 |
| 70 | RXR_22108803_ChIP-Seq_LS180_Human | 0.85017547 |
| 71 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84828941 |
| 72 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.83459650 |
| 73 | TP53_16413492_ChIP-PET_HCT116_Human | 0.83451925 |
| 74 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.83271098 |
| 75 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.83163324 |
| 76 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82847750 |
| 77 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.81916275 |
| 78 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81631381 |
| 79 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.81486384 |
| 80 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.81048688 |
| 81 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.80851927 |
| 82 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.80623080 |
| 83 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80272526 |
| 84 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.80269382 |
| 85 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.79689297 |
| 86 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.79569126 |
| 87 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79494314 |
| 88 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.79420790 |
| 89 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79198376 |
| 90 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.78994027 |
| 91 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.78735342 |
| 92 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.78336700 |
| 93 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.77912626 |
| 94 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.77750493 |
| 95 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.77026519 |
| 96 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76914526 |
| 97 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.75954688 |
| 98 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.75454732 |
| 99 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.75000588 |
| 100 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.73031721 |
| 101 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.72564800 |
| 102 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.72549336 |
| 103 | * EGR1_19032775_ChIP-ChIP_M12_Human | 0.71846431 |
| 104 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.71072784 |
| 105 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.70621405 |
| 106 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.70155268 |
| 107 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.69491665 |
| 108 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.69297618 |
| 109 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.69243308 |
| 110 | ATF3_27146783_Chip-Seq_COLON_Human | 0.68325343 |
| 111 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.67280251 |
| 112 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.66191997 |
| 113 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.64122212 |
| 114 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.63244926 |
| 115 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.63058473 |
| 116 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.62547153 |
| 117 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.61017689 |
| 118 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.58728588 |
| 119 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.58445761 |
| 120 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.58226419 |
| 121 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.57916437 |
| 122 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.56229874 |
| 123 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.56114911 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.00589025 |
| 2 | MP0005360_urolithiasis | 4.91489359 |
| 3 | * MP0002796_impaired_skin_barrier | 4.39717107 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.34292297 |
| 5 | MP0005365_abnormal_bile_salt | 3.81232794 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 3.65052405 |
| 7 | MP0002254_reproductive_system_inflammat | 3.33335137 |
| 8 | MP0004381_abnormal_hair_follicle | 3.19244871 |
| 9 | MP0003941_abnormal_skin_development | 3.17984216 |
| 10 | MP0005275_abnormal_skin_tensile | 3.13233017 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 3.02803512 |
| 12 | MP0000579_abnormal_nail_morphology | 2.98450163 |
| 13 | MP0000383_abnormal_hair_follicle | 2.91157711 |
| 14 | MP0002098_abnormal_vibrissa_morphology | 2.66616301 |
| 15 | MP0003252_abnormal_bile_duct | 2.65322495 |
| 16 | MP0010678_abnormal_skin_adnexa | 2.62589638 |
| 17 | MP0002060_abnormal_skin_morphology | 2.61698018 |
| 18 | * MP0005501_abnormal_skin_physiology | 2.55110525 |
| 19 | MP0003705_abnormal_hypodermis_morpholog | 2.48086748 |
| 20 | MP0010329_abnormal_lipoprotein_level | 2.37387958 |
| 21 | MP0003453_abnormal_keratinocyte_physiol | 2.30743427 |
| 22 | * MP0001216_abnormal_epidermal_layer | 2.27344753 |
| 23 | MP0003011_delayed_dark_adaptation | 2.23007748 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 2.20122370 |
| 25 | MP0000647_abnormal_sebaceous_gland | 2.19236765 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 2.10484054 |
| 27 | MP0003806_abnormal_nucleotide_metabolis | 2.08632389 |
| 28 | MP0000377_abnormal_hair_follicle | 2.04942148 |
| 29 | MP0009840_abnormal_foam_cell | 1.97239568 |
| 30 | MP0000427_abnormal_hair_cycle | 1.93103820 |
| 31 | MP0000566_synostosis | 1.91908166 |
| 32 | MP0005451_abnormal_body_composition | 1.86928014 |
| 33 | MP0009780_abnormal_chondrocyte_physiolo | 1.86780787 |
| 34 | MP0005083_abnormal_biliary_tract | 1.86349418 |
| 35 | * MP0010771_integument_phenotype | 1.85796912 |
| 36 | MP0001666_abnormal_nutrient_absorption | 1.85615901 |
| 37 | MP0003195_calcinosis | 1.85589728 |
| 38 | MP0000467_abnormal_esophagus_morphology | 1.77690433 |
| 39 | MP0005409_darkened_coat_color | 1.72836326 |
| 40 | MP0004947_skin_inflammation | 1.67904894 |
| 41 | MP0005332_abnormal_amino_acid | 1.51041061 |
| 42 | MP0009053_abnormal_anal_canal | 1.48867060 |
| 43 | MP0002009_preneoplasia | 1.35565179 |
| 44 | MP0000609_abnormal_liver_physiology | 1.29245491 |
| 45 | MP0002118_abnormal_lipid_homeostasis | 1.28724573 |
| 46 | MP0001346_abnormal_lacrimal_gland | 1.26875927 |
| 47 | MP0000762_abnormal_tongue_morphology | 1.21915849 |
| 48 | MP0001243_abnormal_dermal_layer | 1.21363010 |
| 49 | * MP0009931_abnormal_skin_appearance | 1.21043379 |
| 50 | MP0003566_abnormal_cell_adhesion | 1.19412632 |
| 51 | MP0003950_abnormal_plasma_membrane | 1.13726087 |
| 52 | MP0002138_abnormal_hepatobiliary_system | 1.12909497 |
| 53 | MP0001191_abnormal_skin_condition | 1.10963399 |
| 54 | MP0009384_cardiac_valve_regurgitation | 1.10542402 |
| 55 | * MP0000367_abnormal_coat/_hair | 1.03046713 |
| 56 | MP0005647_abnormal_sex_gland | 0.97580366 |
| 57 | MP0000858_altered_metastatic_potential | 0.97300697 |
| 58 | MP0009379_abnormal_foot_pigmentation | 0.94750744 |
| 59 | MP0001849_ear_inflammation | 0.93819987 |
| 60 | MP0002876_abnormal_thyroid_physiology | 0.93238166 |
| 61 | MP0002089_abnormal_postnatal_growth/wei | 0.92815477 |
| 62 | MP0005257_abnormal_intraocular_pressure | 0.91281227 |
| 63 | MP0005319_abnormal_enzyme/_coenzyme | 0.88143067 |
| 64 | MP0002877_abnormal_melanocyte_morpholog | 0.84024716 |
| 65 | MP0005023_abnormal_wound_healing | 0.83477360 |
| 66 | MP0009643_abnormal_urine_homeostasis | 0.83397300 |
| 67 | MP0005076_abnormal_cell_differentiation | 0.81498483 |
| 68 | MP0001851_eye_inflammation | 0.78270145 |
| 69 | MP0001340_abnormal_eyelid_morphology | 0.77715670 |
| 70 | MP0004264_abnormal_extraembryonic_tissu | 0.77691549 |
| 71 | MP0005164_abnormal_response_to | 0.76822207 |
| 72 | MP0004185_abnormal_adipocyte_glucose | 0.76665870 |
| 73 | MP0009764_decreased_sensitivity_to | 0.74669179 |
| 74 | MP0003868_abnormal_feces_composition | 0.73703270 |
| 75 | MP0010368_abnormal_lymphatic_system | 0.73502157 |
| 76 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.72319396 |
| 77 | MP0002234_abnormal_pharynx_morphology | 0.71487059 |
| 78 | MP0001915_intracranial_hemorrhage | 0.70371113 |
| 79 | MP0003091_abnormal_cell_migration | 0.70241068 |
| 80 | MP0005408_hypopigmentation | 0.68819615 |
| 81 | MP0001764_abnormal_homeostasis | 0.68300326 |
| 82 | MP0001661_extended_life_span | 0.68261683 |
| 83 | MP0004272_abnormal_basement_membrane | 0.67718935 |
| 84 | MP0002168_other_aberrant_phenotype | 0.67575160 |
| 85 | MP0000604_amyloidosis | 0.67106623 |
| 86 | MP0010030_abnormal_orbit_morphology | 0.66704154 |
| 87 | MP0000627_abnormal_mammary_gland | 0.66244143 |
| 88 | MP0000537_abnormal_urethra_morphology | 0.63930980 |
| 89 | MP0005636_abnormal_mineral_homeostasis | 0.63183222 |
| 90 | MP0002896_abnormal_bone_mineralization | 0.62234669 |
| 91 | MP0005197_abnormal_uvea_morphology | 0.59199358 |
| 92 | MP0009763_increased_sensitivity_to | 0.57043898 |
| 93 | MP0003436_decreased_susceptibility_to | 0.56883099 |
| 94 | MP0003638_abnormal_response/metabolism_ | 0.56386411 |
| 95 | MP0005248_abnormal_Harderian_gland | 0.55766696 |
| 96 | MP0002166_altered_tumor_susceptibility | 0.55569241 |
| 97 | MP0000538_abnormal_urinary_bladder | 0.55471053 |
| 98 | MP0003045_fibrosis | 0.55306543 |
| 99 | MP0005058_abnormal_lysosome_morphology | 0.54995895 |
| 100 | MP0004782_abnormal_surfactant_physiolog | 0.54647924 |
| 101 | MP0003300_gastrointestinal_ulcer | 0.54187986 |
| 102 | MP0002282_abnormal_trachea_morphology | 0.53047241 |
| 103 | MP0008438_abnormal_cutaneous_collagen | 0.52231897 |
| 104 | MP0005075_abnormal_melanosome_morpholog | 0.51740796 |
| 105 | MP0001853_heart_inflammation | 0.51399192 |
| 106 | MP0004883_abnormal_blood_vessel | 0.51277316 |
| 107 | MP0000462_abnormal_digestive_system | 0.50442183 |
| 108 | MP0000598_abnormal_liver_morphology | 0.50383724 |
| 109 | MP0009697_abnormal_copulation | 0.50058087 |
| 110 | MP0005220_abnormal_exocrine_pancreas | 0.49620556 |
| 111 | MP0002697_abnormal_eye_size | 0.49466857 |
| 112 | MP0000003_abnormal_adipose_tissue | 0.48556132 |
| 113 | MP0003186_abnormal_redox_activity | 0.48441447 |
| 114 | MP0009765_abnormal_xenobiotic_induced | 0.48053871 |
| 115 | MP0010352_gastrointestinal_tract_polyps | 0.47878443 |
| 116 | MP0001881_abnormal_mammary_gland | 0.47355106 |
| 117 | MP0003755_abnormal_palate_morphology | 0.46668843 |
| 118 | MP0008469_abnormal_protein_level | 0.43557262 |
| 119 | MP0002136_abnormal_kidney_physiology | 0.43383081 |
| 120 | MP0002233_abnormal_nose_morphology | 0.42114914 |
| 121 | MP0002249_abnormal_larynx_morphology | 0.41310740 |
| 122 | MP0005193_abnormal_anterior_eye | 0.41237900 |
| 123 | MP0003724_increased_susceptibility_to | 0.40635781 |
| 124 | MP0005187_abnormal_penis_morphology | 0.40064080 |
| 125 | MP0009642_abnormal_blood_homeostasis | 0.39464651 |
| 126 | MP0001756_abnormal_urination | 0.38813637 |
| 127 | MP0002971_abnormal_brown_adipose | 0.38788546 |
| 128 | MP0003656_abnormal_erythrocyte_physiolo | 0.36423594 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.09241142 |
| 2 | Deep venous thrombosis (HP:0002625) | 5.85557964 |
| 3 | Xanthomatosis (HP:0000991) | 5.50914230 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 5.13207747 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.97852241 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.95572281 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 4.65126288 |
| 8 | Right ventricular cardiomyopathy (HP:0011663) | 4.51259102 |
| 9 | Onycholysis (HP:0001806) | 4.50842904 |
| 10 | Epidermoid cyst (HP:0200040) | 4.44600288 |
| 11 | Complement deficiency (HP:0004431) | 4.37047081 |
| 12 | Plantar hyperkeratosis (HP:0007556) | 4.36532482 |
| 13 | Fragile nails (HP:0001808) | 4.12878842 |
| 14 | Woolly hair (HP:0002224) | 4.11900105 |
| 15 | * Hypotrichosis (HP:0001006) | 4.08501108 |
| 16 | Hyperlipoproteinemia (HP:0010980) | 4.03750142 |
| 17 | Hypolipoproteinemia (HP:0010981) | 3.94743671 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 3.81832877 |
| 19 | Palmoplantar hyperkeratosis (HP:0000972) | 3.72730209 |
| 20 | Abnormality of nail color (HP:0100643) | 3.62889427 |
| 21 | Abnormality of the common coagulation pathway (HP:0010990) | 3.62548016 |
| 22 | Joint hemorrhage (HP:0005261) | 3.61095538 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.57480228 |
| 24 | Palmar hyperkeratosis (HP:0010765) | 3.45063628 |
| 25 | Milia (HP:0001056) | 3.43979708 |
| 26 | Abnormality of complement system (HP:0005339) | 3.42847380 |
| 27 | Lip pit (HP:0100267) | 3.41916253 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.28951114 |
| 29 | Vascular calcification (HP:0004934) | 3.27484814 |
| 30 | Fat malabsorption (HP:0002630) | 3.22155266 |
| 31 | Amelogenesis imperfecta (HP:0000705) | 3.21902010 |
| 32 | Hyperammonemia (HP:0001987) | 3.11875420 |
| 33 | Hyperglycinemia (HP:0002154) | 3.10910972 |
| 34 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.07927652 |
| 35 | Abnormality of the salivary glands (HP:0010286) | 3.07061553 |
| 36 | Pili torti (HP:0003777) | 3.01402141 |
| 37 | Cardiovascular calcification (HP:0011915) | 2.97793821 |
| 38 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.96103818 |
| 39 | Conjugated hyperbilirubinemia (HP:0002908) | 2.89886031 |
| 40 | Erythroderma (HP:0001019) | 2.89194104 |
| 41 | Ketosis (HP:0001946) | 2.86000551 |
| 42 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.85633975 |
| 43 | Hyperglycinuria (HP:0003108) | 2.82768354 |
| 44 | Myocardial infarction (HP:0001658) | 2.81753362 |
| 45 | Alopecia of scalp (HP:0002293) | 2.81707103 |
| 46 | Abnormality of methionine metabolism (HP:0010901) | 2.80856372 |
| 47 | Absent eyelashes (HP:0000561) | 2.79330853 |
| 48 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.76987806 |
| 49 | Abnormality of glycine metabolism (HP:0010895) | 2.76987806 |
| 50 | Nail dystrophy (HP:0008404) | 2.75440381 |
| 51 | Erythema (HP:0010783) | 2.65689441 |
| 52 | Hypoglycemic coma (HP:0001325) | 2.65110017 |
| 53 | Increased IgE level (HP:0003212) | 2.63959196 |
| 54 | Hypercholesterolemia (HP:0003124) | 2.61265954 |
| 55 | Atrophic scars (HP:0001075) | 2.57327466 |
| 56 | Abnormality of the labia majora (HP:0012881) | 2.57120420 |
| 57 | Abnormality of the intrinsic pathway (HP:0010989) | 2.55848394 |
| 58 | Abnormality of secondary sexual hair (HP:0009888) | 2.54208538 |
| 59 | Abnormality of the axillary hair (HP:0100134) | 2.54208538 |
| 60 | Abnormal blistering of the skin (HP:0008066) | 2.51468706 |
| 61 | Neonatal death (HP:0003811) | 2.50572479 |
| 62 | Thick nail (HP:0001805) | 2.50386566 |
| 63 | Abnormality of the dental root (HP:0006486) | 2.49326247 |
| 64 | Taurodontia (HP:0000679) | 2.49326247 |
| 65 | Abnormality of permanent molar morphology (HP:0011071) | 2.49326247 |
| 66 | Corneal erosion (HP:0200020) | 2.47999333 |
| 67 | * Sparse eyelashes (HP:0000653) | 2.46183255 |
| 68 | Abnormal hair laboratory examination (HP:0003328) | 2.41904761 |
| 69 | Spontaneous abortion (HP:0005268) | 2.41405045 |
| 70 | Pterygium (HP:0001059) | 2.40802243 |
| 71 | Selective tooth agenesis (HP:0001592) | 2.40448492 |
| 72 | Ridged nail (HP:0001807) | 2.40079621 |
| 73 | Steatorrhea (HP:0002570) | 2.39683125 |
| 74 | Amyloidosis (HP:0011034) | 2.34263084 |
| 75 | Nasolacrimal duct obstruction (HP:0000579) | 2.34243409 |
| 76 | Flat acetabular roof (HP:0003180) | 2.33970362 |
| 77 | * Hypoplasia of dental enamel (HP:0006297) | 2.32289576 |
| 78 | Pruritus (HP:0000989) | 2.31549513 |
| 79 | Popliteal pterygium (HP:0009756) | 2.30978712 |
| 80 | Abnormality of molar (HP:0011077) | 2.30889029 |
| 81 | Abnormality of molar morphology (HP:0011070) | 2.30889029 |
| 82 | Abnormality of the dental pulp (HP:0006479) | 2.29463796 |
| 83 | Advanced eruption of teeth (HP:0006288) | 2.28374446 |
| 84 | Hyperbilirubinemia (HP:0002904) | 2.27488960 |
| 85 | Malnutrition (HP:0004395) | 2.26527776 |
| 86 | Rickets (HP:0002748) | 2.25991871 |
| 87 | Sparse scalp hair (HP:0002209) | 2.25724882 |
| 88 | Systemic lupus erythematosus (HP:0002725) | 2.24425566 |
| 89 | Natal tooth (HP:0000695) | 2.24171281 |
| 90 | Hepatocellular carcinoma (HP:0001402) | 2.22702558 |
| 91 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.21925301 |
| 92 | Delayed CNS myelination (HP:0002188) | 2.19174446 |
| 93 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.18646664 |
| 94 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.18360489 |
| 95 | Nephritis (HP:0000123) | 2.17647414 |
| 96 | Aplasia involving bones of the extremities (HP:0009825) | 2.16643251 |
| 97 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.16643251 |
| 98 | Aplasia of the phalanges of the hand (HP:0009802) | 2.16643251 |
| 99 | Gangrene (HP:0100758) | 2.14705241 |
| 100 | Xerostomia (HP:0000217) | 2.14463710 |
| 101 | Septate vagina (HP:0001153) | 2.13744882 |
| 102 | Neonatal onset (HP:0003623) | 2.13387792 |
| 103 | Ankyloglossia (HP:0010296) | 2.11647831 |
| 104 | Split foot (HP:0001839) | 2.11108314 |
| 105 | Glomerulonephritis (HP:0000099) | 2.10538047 |
| 106 | Blepharitis (HP:0000498) | 2.08772733 |
| 107 | Abnormality of nucleobase metabolism (HP:0010932) | 2.07255334 |
| 108 | Conical tooth (HP:0000698) | 2.06969676 |
| 109 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.06667968 |
| 110 | Palmoplantar keratoderma (HP:0000982) | 2.05926501 |
| 111 | Gingival bleeding (HP:0000225) | 2.01992538 |
| 112 | Abnormality of purine metabolism (HP:0004352) | 2.01702757 |
| 113 | Fragile skin (HP:0001030) | 2.00873410 |
| 114 | Ketoacidosis (HP:0001993) | 1.99613564 |
| 115 | Abnormality of the gastric mucosa (HP:0004295) | 1.98984669 |
| 116 | Conjunctival hamartoma (HP:0100780) | 1.98612729 |
| 117 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.98248508 |
| 118 | Arterial tortuosity (HP:0005116) | 1.97924448 |
| 119 | Mitral stenosis (HP:0001718) | 1.97117045 |
| 120 | Hypophosphatemic rickets (HP:0004912) | 1.95071994 |
| 121 | Hypohidrosis (HP:0000966) | 1.93970141 |
| 122 | Skin nodule (HP:0200036) | 1.93909356 |
| 123 | Abnormality of the lacrimal duct (HP:0011481) | 1.92370686 |
| 124 | Hypoplastic labia majora (HP:0000059) | 1.92079018 |
| 125 | Bifid scrotum (HP:0000048) | 1.91501964 |
| 126 | Curly hair (HP:0002212) | 1.90980776 |
| 127 | Short nail (HP:0001799) | 1.89856639 |
| 128 | Esophageal varix (HP:0002040) | 1.88097847 |
| 129 | Acanthocytosis (HP:0001927) | 1.87627683 |
| 130 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.86813531 |
| 131 | Abnormality of the Achilles tendon (HP:0005109) | 1.85650476 |
| 132 | Hyporeflexia of lower limbs (HP:0002600) | 1.83921144 |
| 133 | Menorrhagia (HP:0000132) | 1.82782768 |
| 134 | Hypochromic microcytic anemia (HP:0004840) | 1.81485257 |
| 135 | Abnormality of carpal bone ossification (HP:0006257) | 1.79479302 |
| 136 | Brittle hair (HP:0002299) | 1.79263299 |
| 137 | Abnormality of serum amino acid levels (HP:0003112) | 1.78816746 |
| 138 | Ectropion (HP:0000656) | 1.77621397 |
| 139 | Labial hypoplasia (HP:0000066) | 1.75135954 |
| 140 | Abnormality of the nasal septum (HP:0000419) | 1.74074097 |
| 141 | Hemorrhage of the eye (HP:0011885) | 1.73935373 |
| 142 | Dry hair (HP:0011359) | 1.72285749 |
| 143 | Absent hair (HP:0002298) | 1.71287483 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 4.85763536 |
| 2 | FGFR4 | 3.44591968 |
| 3 | MAP3K3 | 3.32147528 |
| 4 | ERN1 | 2.93765708 |
| 5 | MAPKAPK3 | 2.93708259 |
| 6 | EPHB2 | 2.83536057 |
| 7 | MST4 | 2.79642113 |
| 8 | LATS1 | 2.77802766 |
| 9 | BCKDK | 2.64520503 |
| 10 | FER | 2.60392063 |
| 11 | SIK1 | 2.53786865 |
| 12 | EPHA2 | 2.26093674 |
| 13 | FGFR2 | 2.23818982 |
| 14 | MAP3K2 | 2.13540752 |
| 15 | ERBB4 | 2.04194606 |
| 16 | PIK3CG | 2.04039984 |
| 17 | TRPM7 | 1.99210501 |
| 18 | MAP3K12 | 1.98476252 |
| 19 | LMTK2 | 1.97529782 |
| 20 | PTK6 | 1.76809474 |
| 21 | EPHA3 | 1.73712014 |
| 22 | TGFBR1 | 1.72403414 |
| 23 | MET | 1.70373236 |
| 24 | CDK12 | 1.68840193 |
| 25 | PAK4 | 1.57896773 |
| 26 | ICK | 1.51799035 |
| 27 | TESK1 | 1.46327915 |
| 28 | FRK | 1.45882457 |
| 29 | SMG1 | 1.44319582 |
| 30 | EPHB1 | 1.41737464 |
| 31 | TYK2 | 1.40305402 |
| 32 | LRRK2 | 1.39628733 |
| 33 | NTRK1 | 1.38652624 |
| 34 | MAP3K6 | 1.37819301 |
| 35 | TGFBR2 | 1.35042587 |
| 36 | MAP3K7 | 1.34546017 |
| 37 | RPS6KB2 | 1.33723651 |
| 38 | MAP3K14 | 1.31034659 |
| 39 | FGFR3 | 1.28231972 |
| 40 | NEK9 | 1.26658381 |
| 41 | MAP3K1 | 1.25677079 |
| 42 | ERBB2 | 1.22650111 |
| 43 | MAPK15 | 1.17611857 |
| 44 | STK10 | 1.17332534 |
| 45 | TRIB3 | 1.16643571 |
| 46 | DYRK1B | 1.16291738 |
| 47 | MYLK | 1.10367165 |
| 48 | BCR | 1.09752045 |
| 49 | EEF2K | 1.08975162 |
| 50 | MAP3K9 | 1.07115875 |
| 51 | MAPK11 | 1.04269117 |
| 52 | ERBB3 | 1.01248121 |
| 53 | INSRR | 0.97706250 |
| 54 | CDK6 | 0.95485705 |
| 55 | STK38 | 0.93631834 |
| 56 | DMPK | 0.92297759 |
| 57 | MAP2K2 | 0.92121970 |
| 58 | PTK2 | 0.87165055 |
| 59 | JAK2 | 0.86652540 |
| 60 | MAP2K4 | 0.86099784 |
| 61 | GRK1 | 0.81800474 |
| 62 | MTOR | 0.80007362 |
| 63 | GSK3A | 0.79676907 |
| 64 | TBK1 | 0.73312227 |
| 65 | FGFR1 | 0.69619723 |
| 66 | IKBKE | 0.68074279 |
| 67 | TAOK3 | 0.67075347 |
| 68 | MAPK4 | 0.66519703 |
| 69 | PRKAA2 | 0.64707791 |
| 70 | CHUK | 0.64013279 |
| 71 | ARAF | 0.61832523 |
| 72 | ABL2 | 0.61404625 |
| 73 | MAP2K6 | 0.61330827 |
| 74 | MAP3K13 | 0.60250514 |
| 75 | JAK1 | 0.58630397 |
| 76 | EIF2AK1 | 0.57013901 |
| 77 | NEK6 | 0.55389427 |
| 78 | SCYL2 | 0.55276175 |
| 79 | PRKCZ | 0.55260627 |
| 80 | MAP2K3 | 0.54960294 |
| 81 | PDGFRB | 0.54006934 |
| 82 | CDK3 | 0.52118882 |
| 83 | PAK2 | 0.51896512 |
| 84 | MAP2K1 | 0.51125901 |
| 85 | CDC42BPA | 0.51076708 |
| 86 | RIPK1 | 0.50610662 |
| 87 | STK38L | 0.49956888 |
| 88 | MAPK12 | 0.48632905 |
| 89 | MAP3K11 | 0.48381864 |
| 90 | STK3 | 0.47748537 |
| 91 | PDGFRA | 0.47698503 |
| 92 | MAPKAPK5 | 0.47445475 |
| 93 | LATS2 | 0.45882254 |
| 94 | PIM2 | 0.44807007 |
| 95 | PRKACG | 0.44336351 |
| 96 | BMX | 0.43677601 |
| 97 | ILK | 0.42958044 |
| 98 | SIK3 | 0.42909565 |
| 99 | RPS6KA2 | 0.42411446 |
| 100 | PKN1 | 0.42273314 |
| 101 | BLK | 0.42147791 |
| 102 | PRKD1 | 0.41755480 |
| 103 | SGK3 | 0.41563897 |
| 104 | RPS6KB1 | 0.41269330 |
| 105 | STK24 | 0.40859770 |
| 106 | MAPKAPK2 | 0.40733634 |
| 107 | IKBKB | 0.40206585 |
| 108 | TTN | 0.39933284 |
| 109 | PIK3CA | 0.39882247 |
| 110 | PKN2 | 0.39613721 |
| 111 | IGF1R | 0.39240935 |
| 112 | EPHA4 | 0.37342527 |
| 113 | MELK | 0.36824534 |
| 114 | RPS6KA1 | 0.35026394 |
| 115 | IRAK1 | 0.34962270 |
| 116 | EGFR | 0.34604746 |
| 117 | RET | 0.34469411 |
| 118 | KSR2 | 0.34173351 |
| 119 | CDK9 | 0.34050755 |
| 120 | MAPK7 | 0.33795701 |
| 121 | ABL1 | 0.33603525 |
| 122 | NLK | 0.32174186 |
| 123 | CDK8 | 0.32068282 |
| 124 | MAP3K5 | 0.31667501 |
| 125 | FLT3 | 0.31138988 |
| 126 | ITK | 0.30713256 |
| 127 | PRPF4B | 0.30639033 |
| 128 | PRKCQ | 0.30192808 |
| 129 | PRKCE | 0.29426715 |
| 130 | PBK | 0.28058066 |
| 131 | ROCK1 | 0.27916152 |
| 132 | BRSK2 | 0.27555370 |
| 133 | MAPK3 | 0.27462362 |
| 134 | TAOK1 | 0.26915127 |
| 135 | IRAK3 | 0.26763991 |
| 136 | CSNK1D | 0.26603606 |
| 137 | SRC | 0.26148819 |
| 138 | LIMK1 | 0.24999779 |
| 139 | PDPK1 | 0.23305870 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.35729936 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.43554998 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.97637102 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.95758124 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.93996659 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.68132140 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.50234173 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.42261805 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.40699449 |
| 10 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.37491791 |
| 11 | Histidine metabolism_Homo sapiens_hsa00340 | 2.34750194 |
| 12 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.27802572 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.27532030 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.14381833 |
| 15 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.12634436 |
| 16 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.12037380 |
| 17 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.08791038 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.07362298 |
| 19 | Retinol metabolism_Homo sapiens_hsa00830 | 2.04977902 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.97355919 |
| 21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.96782839 |
| 22 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.88503233 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88107547 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.86599471 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.82772685 |
| 26 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.81444872 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.79991128 |
| 28 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.75641199 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.74965574 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73916133 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.73863793 |
| 32 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.59877298 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.38583725 |
| 34 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.36380673 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.34611621 |
| 36 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.33983533 |
| 37 | ABC transporters_Homo sapiens_hsa02010 | 1.33204292 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.32366158 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30719512 |
| 40 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.29719160 |
| 41 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.25735580 |
| 42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.18448662 |
| 43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.18032742 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.06464670 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.06073850 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.00042616 |
| 47 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.94783099 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.91397644 |
| 49 | Thyroid cancer_Homo sapiens_hsa05216 | 0.91096901 |
| 50 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.87487799 |
| 51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.82910095 |
| 52 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82365120 |
| 53 | Other glycan degradation_Homo sapiens_hsa00511 | 0.80457000 |
| 54 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.77969561 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.77291669 |
| 56 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.75194929 |
| 57 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.74991569 |
| 58 | Focal adhesion_Homo sapiens_hsa04510 | 0.74607460 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.70545048 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70527058 |
| 61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.67486235 |
| 62 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66918495 |
| 63 | Carbon metabolism_Homo sapiens_hsa01200 | 0.65479427 |
| 64 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.63268925 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.61253356 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59701186 |
| 67 | Sulfur relay system_Homo sapiens_hsa04122 | 0.56685528 |
| 68 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53507977 |
| 69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51432698 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.46856423 |
| 71 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.46266134 |
| 72 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.44865571 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44557619 |
| 74 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.44176444 |
| 75 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.43234256 |
| 76 | Circadian rhythm_Homo sapiens_hsa04710 | 0.42826659 |
| 77 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41576233 |
| 78 | * Tight junction_Homo sapiens_hsa04530 | 0.40536335 |
| 79 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.38979224 |
| 80 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.37007526 |
| 81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36142442 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.36134235 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35887934 |
| 84 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.34039350 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | 0.33897389 |
| 86 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.33669308 |
| 87 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.31533630 |
| 88 | Bladder cancer_Homo sapiens_hsa05219 | 0.31341556 |
| 89 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.30738551 |
| 90 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28578685 |
| 91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.26568174 |
| 92 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.26324846 |
| 93 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.26230585 |
| 94 | Lysosome_Homo sapiens_hsa04142 | 0.23784849 |
| 95 | Prion diseases_Homo sapiens_hsa05020 | 0.22788054 |
| 96 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.20831804 |
| 97 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.20816952 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.20162653 |
| 99 | Prostate cancer_Homo sapiens_hsa05215 | 0.20120147 |
| 100 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.20087220 |
| 101 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.19364739 |
| 102 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.18926268 |
| 103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.17802975 |
| 104 | Adherens junction_Homo sapiens_hsa04520 | 0.16372323 |
| 105 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.15746495 |
| 106 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.15554434 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13852751 |
| 108 | Mineral absorption_Homo sapiens_hsa04978 | 0.12983421 |
| 109 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.12894714 |
| 110 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.11083689 |
| 111 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.05878788 |
| 112 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.04705470 |
| 113 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.03824009 |
| 114 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.03601267 |
| 115 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.01850948 |
| 116 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.00815130 |
| 117 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00789098 |
| 118 | Melanogenesis_Homo sapiens_hsa04916 | -0.0640659 |
| 119 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | -0.0525726 |
| 120 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | -0.0386484 |
| 121 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | -0.0270247 |
| 122 | Galactose metabolism_Homo sapiens_hsa00052 | -0.0242249 |
| 123 | * Hepatitis C_Homo sapiens_hsa05160 | -0.0175609 |
| 124 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | -0.0147571 |
| 125 | Pertussis_Homo sapiens_hsa05133 | -0.0104359 |
| 126 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | -0.0021095 |

